Sofinnova Venture Partners X, L.P. → Vera Therapeutics, Inc. VERA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (7.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 7.17

13,587,185 shares short · -21.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $88.03M

Point72 Asset Mgmt

Other 13D/G Filings on Vera Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2023-07-05	SC	Carlyle Group Inc.	—	—	view →

Other Filings by Sofinnova Venture Partners X, L.P.

Filed	Form	Issuer	Stake	Shares
2024-02-20	SC	Aerovate Therapeutics, Inc. JBIO	—	—	view →
2023-06-21	SC	Karuna Therapeutics, Inc.	—	—	view →
2023-03-01	SC	CinCor Pharma, Inc.	—	—	view →
2022-08-22	SC	CinCor Pharma, Inc.	—	—	view →
2022-02-15	SC	Y-mAbs Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →